
The Group acquired a 31% controlling stake in Fortis in 2018, which triggered a mandatory open offer to acquire another 26% of Fortis shares from the market. The open offer has not proceeded due to ongoing legal proceedings due to the matter pending before the Supreme Court.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LsArnmI
via
IFTTT
0 comments:
Post a Comment